TIP 43: Opioid Treatment
By Ellen Robinson
SAMHSA
recently released new guidelines on medication-assisted treatment
in Opioid Treatment Programs (OTPs), which largely provide services
to people addicted to heroin or prescription drugs containing opiates.
Targeted to treatment providers and administrators
in OTPs, Medication-Assisted
Treatment for Opioid Addiction in Opioid Treatment Programs,
SAMHSA's Treatment Improvement Protocol 43 (TIP 43),
provides updated information on effective treatment practices
and care.
The TIP emphasizes the importance of support services such as
counseling, mental health, and related medical services, as well
as vocational rehabilitation. TIP 43 consolidates and updates earlier
TIPs on methadone treatment for opioid dependence. The new TIP also
complements TIP 40, Clinical Guidelines for the Use of Buprenorphine
in the Treatment of Opioid Addiction.
Currently, there are more than 1,100 OTPs operating in the United
States. According to the guide, medication-assisted treatment offers
a more comprehensive, individually tailored program than other types
of treatment. Medication-assisted treatment includes pharmacotherapy
integrated with psychosocial and medical treatment and support services.
The guide emphasizes that opioid dependence is a treatable medical
disorder. To support patients in recovery, TIP 43 highlights ways
to combat the effects of stigma in communities.
Representative chapters include:
Chapter 1: Introduction provides an overview
of medication-assisted treatment, an update on the changing field
of treatment for opioid dependence, and possibilities for the future.
Chapter 2: History of Medication-Assisted Treatment for
Opioid Addiction reviews the background of opioid addiction
and treatment. This chapter also includes information on new regulations
affecting opioid addiction treatment.
Chapter 3: Pharmacology of Medications Used
To Treat Opioid Addiction compares the types
of medications used and includes detailed descriptions
of the pros and cons of these medications. This chapter
also outlines best practices for the use of three specific
medicines—methadone, buprenorphine, and naltrexone—to
treat those addicted to opioids.
Methadone is a synthetic opioid that has been successful over
many years in treating addiction to opiates. Buprenorphine can be
prescribed—in office-based settings—by physicians with
appropriate certification. Naltrexone blocks the effects of heroin
or prescription drugs containing opiates.
Chapter 4: Initial Screening, Admission Procedures, and
Assessment Techniques discusses the procedures used to
screen, admit, and assess patients in OTPs. This chapter also offers
assessment techniques and considerations that are important to ongoing
medication-assisted treatment.
Chapter 5: Clinical Pharmacotherapy explains
the distinct stages of opioid pharmacotherapy and offers recommendations
on induction, stabilization, appropriate dosage, and medically supervised
withdrawal.
Chapter 6: Patient-Treatment Matching: Types of Services
and Levels of Care offers an in-depth strategy for matching
patients with types of treatment and presents ways to accommodate
special populations.
Chapter 7: Phases of Treatment outlines each
phase of the treatment process in detail—acute, rehabilitative,
supportive care, medical maintenance, tapering, and readjustment
and continuing care.
Chapter 8: Approaches to Providing Comprehensive Care
and Maximizing Patient Retention looks at the use of a
combination of pharmacotherapy and other services when needed—for
example, psychosocial counseling and medical care—as a way
to achieve maximum effectiveness in OTPs. This chapter also describes
ways to increase patient retention and avoid administrative discharge
and non-compliance.
Chapter 9: Drug Testing as a Tool updates earlier
published information on methods for drug testing in OTPs. This
chapter describes the benefits and limitations of a variety of testing
methods—urine, oral-fluid, blood, sweat, and hair. Most discussion,
however, focuses on urine drug testing—the most common method
in OTPs.
Chapter 10: Associated Medical Problems outlines
diagnosis and treatment of the medical conditions most commonly
seen in patients in medication-assisted treatment. These conditions
include HIV/AIDS, hepatitis C, and tuberculosis.
To obtain TIP 43, Medication-Assisted Treatment for Opioid
Addiction in Opioid Treatment Programs, contact SAMHSA's National
Clearinghouse for Alcohol and Drug Information at P.O. Box 2345,
Rockville, MD 20847-2345. Telephone: 1 (800) 729-6686 (English),
1 (877) 767-8432 (Spanish) or 1 (800) 487-4889 (TDD). Ask for NCADI
No. BKD524. Online, TIP 43 is available at www.kap.samhsa.gov/products/manuals/tips/
numerical.htm. ![End of Article](images/articleend.gif)
Back to Top
To Find TIPs Online
For information and online links to other Treatment
Improvement Protocol (TIP) publications, visit
www.kap.
samhsa.gov/products/manuals/tips/numerical.htm.
You can review the entire TIP series by topic or
by number. ![End of Article](images/articleend.gif)
|
« See Also—Previous
Article
See Also—Next
Article »
Back to Top
|